1.
Lancet Oncol
; 17(3): 277-8, 2016 Mar.
Article
in English
| MEDLINE
| ID: mdl-26827244
Subject(s)
Genes, BRCA1 , Maintenance Chemotherapy , Neoplasm Recurrence, Local/drug therapy , Ovarian Neoplasms/drug therapy , Phthalazines/therapeutic use , Piperazines/therapeutic use , Practice Guidelines as Topic , Administration, Intravenous , Aged , Carboplatin/adverse effects , Carboplatin/therapeutic use , Disease-Free Survival , Female , Germ-Line Mutation , Humans , Middle Aged , Neoplasm Invasiveness/pathology , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/pathology , Neoplasm Staging , Ovarian Neoplasms/genetics , Ovarian Neoplasms/mortality , Ovarian Neoplasms/pathology , Prognosis , Survival Analysis , United Kingdom
2.
Lancet Oncol
; 17(1): 21-2, 2016 Jan.
Article
in English
| MEDLINE
| ID: mdl-26621380
3.
Lancet Respir Med
; 1(3): 189-90, 2013 May.
Article
in English
| MEDLINE
| ID: mdl-24429120